The pharma giant previously received billions in federal funding and raked in huge profits, but owes nothing in 2023 income taxes thanks to legal loopholes and Trump-era tax cuts. Read this story
The pharma giant previously received billions in federal funding and raked in huge profits, but owes nothing in 2023 income taxes thanks to legal loopholes and Trump-era tax cuts. Read this story
More from The Lever | Health Care